Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.
作者信息
Di Capua Mirko, Coppola Antonio, Nardo Assunta, Cimino Ernesto, Di Minno Matteo N D, Tufano Antonella, Mormile Rosaria, Burzo Maria L, Di Minno Giovanni, Cerbone Anna M
机构信息
Regional Reference Centre for Coagulation Disorders, Federico II University Hospital, Naples, Italy.
出版信息
Blood Transfus. 2015 Apr;13(2):328-32. doi: 10.2450/2014.0047-14. Epub 2014 Jun 19.
Abstract
摘要
相似文献
1
Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.重组活化凝血因子 VII 治疗获得性血友病 A 出血的管理：一种方法适用于所有情况吗？四例报告
Blood Transfus. 2015 Apr;13(2):328-32. doi: 10.2450/2014.0047-14. Epub 2014 Jun 19.
2
Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.重组活化凝血因子VII用于治疗遗传性和获得性出血性疾病患者的出血发作。
Transfus Med Rev. 1993 Apr;7(2):78-83. doi: 10.1016/s0887-7963(93)70126-1.
3
Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.使用重组凝血因子VIIa控制有抑制剂的血友病患者的急性出血发作：持续输注和推注注射。
Haemophilia. 2000 Mar;6(2):61-5. doi: 10.1046/j.1365-2516.2000.00380.x.
4
5
6
How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011.我们如何在伴有抑制剂的血友病 A 或 B 患者中使用重组活化因子 VII。澳大利亚和新西兰血液学专家工作组，墨尔本，2011 年 4 月。
Intern Med J. 2012 Nov;42(11):1243-50. doi: 10.1111/j.1445-5994.2012.02942.x.
7
Recombinant factor VIIa in joint and muscle bleeding episodes.重组凝血因子VIIa用于关节和肌肉出血发作时
Haemostasis. 1996;26 Suppl 1:135-8. doi: 10.1159/000217255.
8
Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.WIRK 前瞻性、非干预性观察研究结果：重组活化因子 VII(rFVIIa)治疗伴有抑制剂的先天性血友病和其他出血性疾病患者。
Haemophilia. 2013 Sep;19(5):679-85. doi: 10.1111/hae.12156. Epub 2013 May 7.
9
Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.重组活化凝血因子 VII 治疗获得性血友病 A 急性出血：日本 10 年上市后监测数据分析
Haemophilia. 2017 Jan;23(1):50-58. doi: 10.1111/hae.13033. Epub 2016 Jul 25.
10
The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
Haemophilia. 2009 May;15(3):828-30. doi: 10.1111/j.1365-2516.2008.01927.x.
引用本文的文献
1
Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents.在频繁使用旁路止血剂36天后发生获得性甲型血友病并伴有脑梗死。
Hematol Rep. 2018 Sep 5;10(3):7453. doi: 10.4081/hr.2018.7453.
2
Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases.应用重组活化凝血因子 VII 正确治疗获得性血友病 A 出血：7 例单中心研究
Int J Gen Med. 2016 Nov 3;9:393-399. doi: 10.2147/IJGM.S118422. eCollection 2016.
3
Interventions for treating acute bleeding episodes in people with acquired hemophilia A.治疗获得性血友病A患者急性出血发作的干预措施。
Cochrane Database Syst Rev. 2014 Aug 28;2014(8):CD010761. doi: 10.1002/14651858.CD010761.pub2.
本文引用的文献
1
Acquired haemophilia A: a 2013 update.获得性血友病 A：2013 年更新。
Thromb Haemost. 2013 Dec;110(6):1114-20. doi: 10.1160/TH13-05-0363. Epub 2013 Sep 5.
2
How I manage patients with acquired haemophilia A.如何管理获得性血友病 A 患者。
Br J Haematol. 2013 Apr;161(2):157-65. doi: 10.1111/bjh.12228. Epub 2013 Feb 4.
3
High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review.高剂量人血浆源性FVIII-VWF作为获得性血友病A合并心血管疾病患者的一线治疗：4例病例报告及文献综述
Haemophilia. 2013 Jan;19(1):e50-3. doi: 10.1111/hae.12033. Epub 2012 Oct 11.
4
pdFVIII/VWF may be an alternative treatment for old medical patient with acquired haemophilia A and systemic vascular disease?
Transfus Apher Sci. 2013 Feb;48(1):59-62. doi: 10.1016/j.transci.2012.08.005. Epub 2012 Sep 29.
5
Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.获得性凝血因子抑制剂：第一部分-获得性血友病 A。
Semin Thromb Hemost. 2012 Jul;38(5):433-46. doi: 10.1055/s-0032-1315757. Epub 2012 Jun 27.
6
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.获得性血友病 A 出血的管理：来自欧洲获得性血友病（EACH2）登记处的结果。
Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22.
7
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).获得性血友病 A 的人口统计学和临床数据：来自欧洲获得性血友病登记处（EACH2）的结果。
J Thromb Haemost. 2012 Apr;10(4):622-31. doi: 10.1111/j.1538-7836.2012.04654.x.
8
Recombinant activated factor VII: mechanisms of action and current indications.重组活化因子 VII：作用机制和当前适应证。
Semin Thromb Hemost. 2010 Jul;36(5):485-92. doi: 10.1055/s-0030-1255442. Epub 2010 Jul 14.
9
Consensus recommendations for the diagnosis and treatment of acquired hemophilia A.获得性血友病A诊断与治疗的共识性建议。
BMC Res Notes. 2010 Jun 7;3:161. doi: 10.1186/1756-0500-3-161.
10
Acquired haemophilia a in the elderly: case reports.
Curr Gerontol Geriatr Res. 2010;2010:927503. doi: 10.1155/2010/927503. Epub 2010 Mar 3.
Zotero 插件